W K Hoots
Overview
Explore the profile of W K Hoots including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1445
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kulkarni R, Presley R, Lusher J, Shapiro A, Gill J, Manco-Johnson M, et al.
Haemophilia
. 2016 Nov;
23(2):207-214.
PMID: 27813214
Aim: To describe the prevalence and complications in babies ≤2 years with haemophilia. Methods: We used a standardized collection tool to obtain consented data on eligible babies aged ≤2 years...
2.
Kempton C, Abshire T, Deveras R, Hoots W, Gill J, Kessler C, et al.
Haemophilia
. 2012 Apr;
18(5):798-804.
PMID: 22512291
OBI-1 is a recombinant B-domain deleted porcine factor VIII (FVIII). FVIII treatment in those with haemophilia A may be complicated by the development of anti-FVIII antibodies (inhibitors) leading to a...
3.
4.
Valentino L, Carcao M, Mathew P, Leissinger C, Berntorp E, Blanchette V, et al.
Haemophilia
. 2009 Mar;
15(4):959-65.
PMID: 19320750
No abstract available.
5.
Srivastava A, Hoots W, Soucie J, Ludlam C
Haemophilia
. 2008 Jun;
14 Suppl 3:43-8.
PMID: 18510521
No abstract available.
6.
Hoots W, Ebbesen L, Konkle B, Auerswald G, Roberts H, Weatherall J, et al.
Haemophilia
. 2008 Feb;
14(3):466-75.
PMID: 18282155
Haemophilia patients with inhibitors characteristically have impaired joint function and reduced health-related quality of life (HRQoL). This analysis examined whether secondary prophylaxis with recombinant activated factor VII (rFVIIa) improves HRQoL...
7.
Valentino L, Hakobyan N, Rodriguez N, Hoots W
Haemophilia
. 2007 Oct;
13 Suppl 3:10-3.
PMID: 17822515
Hemarthrosis is a common manifestation of haemophilia, and joint arthropathy remains a frequent complication. Even though the exact mechanisms related to blood-induced joint disease have not yet been fully elucidated,...
8.
Hoots W, Rodriguez N, Boggio L, Valentino L
Haemophilia
. 2007 Oct;
13 Suppl 3:4-9.
PMID: 17822514
Arthropathy remains a major cause of morbidity in patients with haemophilia. Frequent bleeding into the joints leads to joint damage with resultant contractures, joint deformities and arthritis. This in turn...
9.
DiMichele D, Hoots W, Pipe S, Rivard G, Santagostino E
Haemophilia
. 2007 Aug;
13 Suppl 1:1-22.
PMID: 17593277
Although immune tolerance induction (ITI) has been used for 30 years to eliminate inhibitors and restore normal factor pharmacokinetics in patients with hemophilia, there is a paucity of scientific evidence...
10.
Hoots W
Haemophilia
. 2006 Nov;
12 Suppl 6:107-13.
PMID: 17123403
Although up to 80% of high-responding inhibitors in patients with severe factor VIII deficiency can be eliminated using heterogeneous regimens for immune tolerance induction, the residual morbidity in this population...